| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Microfluidics | 23 | 2024 | 653 | 5.510 |
Why?
|
| Microfluidic Analytical Techniques | 18 | 2021 | 803 | 3.100 |
Why?
|
| Cochlea | 9 | 2018 | 845 | 1.900 |
Why?
|
| Drug Delivery Systems | 15 | 2023 | 2224 | 1.890 |
Why?
|
| Cell Culture Techniques | 16 | 2023 | 1667 | 1.730 |
Why?
|
| Micro-Electrical-Mechanical Systems | 4 | 2023 | 31 | 1.400 |
Why?
|
| Extracorporeal Membrane Oxygenation | 5 | 2024 | 1460 | 1.350 |
Why?
|
| Tissue Engineering | 15 | 2014 | 1870 | 1.340 |
Why?
|
| Lab-On-A-Chip Devices | 4 | 2023 | 435 | 1.330 |
Why?
|
| Elastomers | 6 | 2013 | 69 | 1.320 |
Why?
|
| Biomimetics | 3 | 2022 | 172 | 1.280 |
Why?
|
| Labyrinth Diseases | 6 | 2014 | 151 | 1.250 |
Why?
|
| Equipment Design | 18 | 2022 | 3510 | 1.240 |
Why?
|
| Artificial Organs | 4 | 2022 | 150 | 1.180 |
Why?
|
| Biocompatible Materials | 13 | 2013 | 1689 | 1.110 |
Why?
|
| Oxygenators, Membrane | 3 | 2024 | 56 | 1.070 |
Why?
|
| Infusion Pumps | 3 | 2016 | 163 | 1.040 |
Why?
|
| Hepatocytes | 8 | 2018 | 1232 | 0.940 |
Why?
|
| Dimethylpolysiloxanes | 6 | 2016 | 142 | 0.840 |
Why?
|
| Drug Discovery | 5 | 2023 | 1054 | 0.820 |
Why?
|
| Biomimetic Materials | 2 | 2016 | 172 | 0.790 |
Why?
|
| Oxygen | 7 | 2023 | 4222 | 0.760 |
Why?
|
| Pyridinium Compounds | 2 | 2018 | 81 | 0.760 |
Why?
|
| Quaternary Ammonium Compounds | 2 | 2018 | 202 | 0.720 |
Why?
|
| Fluorescent Dyes | 2 | 2018 | 1900 | 0.700 |
Why?
|
| Respiratory Mucosa | 2 | 2021 | 439 | 0.700 |
Why?
|
| Ear, Inner | 4 | 2014 | 425 | 0.670 |
Why?
|
| Guinea Pigs | 9 | 2018 | 1317 | 0.650 |
Why?
|
| Polymers | 6 | 2013 | 1615 | 0.550 |
Why?
|
| Antiviral Agents | 4 | 2024 | 3066 | 0.530 |
Why?
|
| Quinoxalines | 4 | 2015 | 296 | 0.520 |
Why?
|
| Amino Alcohols | 2 | 2013 | 19 | 0.520 |
Why?
|
| Microtechnology | 2 | 2015 | 70 | 0.510 |
Why?
|
| Blood Gas Analysis | 1 | 2016 | 379 | 0.500 |
Why?
|
| Miniaturization | 6 | 2015 | 153 | 0.490 |
Why?
|
| Technology, Pharmaceutical | 2 | 2014 | 84 | 0.490 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2021 | 1952 | 0.480 |
Why?
|
| Drug Evaluation | 1 | 2016 | 642 | 0.470 |
Why?
|
| Tissue Array Analysis | 1 | 2016 | 550 | 0.460 |
Why?
|
| Polyesters | 3 | 2010 | 374 | 0.450 |
Why?
|
| Nylons | 2 | 2010 | 46 | 0.450 |
Why?
|
| Guided Tissue Regeneration | 1 | 2014 | 88 | 0.440 |
Why?
|
| Tissue Scaffolds | 5 | 2010 | 934 | 0.420 |
Why?
|
| Perfusion | 4 | 2023 | 1374 | 0.420 |
Why?
|
| Molecular Imprinting | 1 | 2012 | 12 | 0.410 |
Why?
|
| Microscopy, Confocal | 1 | 2018 | 1967 | 0.400 |
Why?
|
| Tumor Microenvironment | 3 | 2020 | 3874 | 0.380 |
Why?
|
| Nanotechnology | 2 | 2023 | 712 | 0.370 |
Why?
|
| Silicones | 4 | 2023 | 227 | 0.370 |
Why?
|
| Excitatory Amino Acid Antagonists | 3 | 2011 | 448 | 0.370 |
Why?
|
| Cell Adhesion | 9 | 2012 | 3088 | 0.360 |
Why?
|
| Decanoates | 3 | 2008 | 55 | 0.360 |
Why?
|
| Animals | 46 | 2024 | 168253 | 0.350 |
Why?
|
| Influenza, Human | 1 | 2021 | 1517 | 0.350 |
Why?
|
| Glycerol | 4 | 2008 | 274 | 0.350 |
Why?
|
| Endothelium, Vascular | 4 | 2021 | 4430 | 0.340 |
Why?
|
| Microvessels | 3 | 2011 | 574 | 0.340 |
Why?
|
| Models, Biological | 6 | 2020 | 9462 | 0.330 |
Why?
|
| Membranes, Artificial | 4 | 2013 | 366 | 0.330 |
Why?
|
| Photography | 1 | 2012 | 531 | 0.320 |
Why?
|
| Liver | 6 | 2018 | 7531 | 0.310 |
Why?
|
| Nanostructures | 3 | 2013 | 552 | 0.310 |
Why?
|
| Cells, Cultured | 16 | 2021 | 18955 | 0.310 |
Why?
|
| Critical Care | 1 | 2021 | 2697 | 0.300 |
Why?
|
| Coculture Techniques | 3 | 2021 | 1340 | 0.290 |
Why?
|
| Organ Culture Techniques | 1 | 2010 | 794 | 0.290 |
Why?
|
| Quorum Sensing | 1 | 2008 | 137 | 0.290 |
Why?
|
| Cochlear Implants | 4 | 2014 | 338 | 0.290 |
Why?
|
| Nephrons | 1 | 2008 | 168 | 0.280 |
Why?
|
| Blood Vessels | 2 | 2010 | 1113 | 0.270 |
Why?
|
| Perilymph | 3 | 2018 | 50 | 0.260 |
Why?
|
| Injections | 2 | 2018 | 829 | 0.250 |
Why?
|
| Bronchi | 2 | 2021 | 845 | 0.250 |
Why?
|
| Surface Properties | 7 | 2016 | 1160 | 0.240 |
Why?
|
| Respiration | 1 | 2011 | 1657 | 0.230 |
Why?
|
| Lung | 5 | 2023 | 9973 | 0.230 |
Why?
|
| Tissue Distribution | 2 | 2018 | 2265 | 0.230 |
Why?
|
| Gentamicins | 2 | 2018 | 251 | 0.230 |
Why?
|
| Coronavirus Infections | 1 | 2021 | 3080 | 0.220 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2019 | 5296 | 0.220 |
Why?
|
| Materials Testing | 6 | 2016 | 864 | 0.210 |
Why?
|
| Endothelial Cells | 4 | 2023 | 3541 | 0.210 |
Why?
|
| Blood Coagulation | 1 | 2008 | 1154 | 0.210 |
Why?
|
| Ethinyl Estradiol | 1 | 2003 | 113 | 0.200 |
Why?
|
| Premenstrual Syndrome | 1 | 2003 | 109 | 0.200 |
Why?
|
| Oxygenators | 1 | 2022 | 36 | 0.200 |
Why?
|
| Contraceptives, Oral, Combined | 1 | 2003 | 116 | 0.200 |
Why?
|
| Gingivitis | 1 | 2023 | 124 | 0.200 |
Why?
|
| Antineoplastic Agents | 4 | 2020 | 13616 | 0.200 |
Why?
|
| Biological Transport | 2 | 2018 | 2090 | 0.200 |
Why?
|
| Androstenes | 1 | 2003 | 181 | 0.190 |
Why?
|
| Cattle | 3 | 2021 | 3849 | 0.190 |
Why?
|
| Swine | 4 | 2024 | 5915 | 0.190 |
Why?
|
| Humans | 52 | 2024 | 760437 | 0.190 |
Why?
|
| Stents | 1 | 2013 | 3177 | 0.190 |
Why?
|
| Extracellular Matrix | 1 | 2009 | 1725 | 0.180 |
Why?
|
| Equipment Failure Analysis | 4 | 2012 | 847 | 0.180 |
Why?
|
| Models, Theoretical | 2 | 2014 | 3576 | 0.180 |
Why?
|
| Parasites | 1 | 2023 | 160 | 0.180 |
Why?
|
| Collagen | 1 | 2009 | 2637 | 0.180 |
Why?
|
| Bacterial Infections | 1 | 2008 | 1406 | 0.180 |
Why?
|
| Disease Models, Animal | 3 | 2020 | 18216 | 0.170 |
Why?
|
| Dermis | 1 | 2021 | 202 | 0.170 |
Why?
|
| Pharmacokinetics | 2 | 2011 | 86 | 0.170 |
Why?
|
| Wheelchairs | 1 | 1999 | 78 | 0.170 |
Why?
|
| Liver, Artificial | 2 | 2010 | 55 | 0.170 |
Why?
|
| High-Throughput Screening Assays | 2 | 2024 | 934 | 0.170 |
Why?
|
| Tissue Adhesives | 2 | 2013 | 173 | 0.160 |
Why?
|
| Pulmonary Gas Exchange | 2 | 2012 | 379 | 0.160 |
Why?
|
| Epithelial Cells | 4 | 2016 | 3661 | 0.160 |
Why?
|
| Drug Screening Assays, Antitumor | 2 | 2019 | 716 | 0.160 |
Why?
|
| Coronavirus | 1 | 2021 | 153 | 0.160 |
Why?
|
| Xanthenes | 1 | 2018 | 72 | 0.160 |
Why?
|
| Pericytes | 1 | 2021 | 293 | 0.150 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 2018 | 222 | 0.150 |
Why?
|
| Bioreactors | 4 | 2013 | 247 | 0.150 |
Why?
|
| Cell Shape | 3 | 2009 | 370 | 0.150 |
Why?
|
| Organ of Corti | 1 | 2018 | 85 | 0.150 |
Why?
|
| Tissue Culture Techniques | 2 | 2017 | 290 | 0.150 |
Why?
|
| Influenza A virus | 1 | 2021 | 457 | 0.150 |
Why?
|
| Lung Neoplasms | 2 | 2019 | 13312 | 0.150 |
Why?
|
| Therapy, Computer-Assisted | 1 | 1999 | 266 | 0.150 |
Why?
|
| Locomotion | 1 | 1999 | 388 | 0.140 |
Why?
|
| Neoplasms | 2 | 2023 | 22083 | 0.140 |
Why?
|
| Cells, Immobilized | 1 | 2016 | 35 | 0.140 |
Why?
|
| Silicon | 4 | 2008 | 142 | 0.140 |
Why?
|
| Transduction, Genetic | 1 | 2019 | 901 | 0.140 |
Why?
|
| Lentivirus | 1 | 2019 | 508 | 0.140 |
Why?
|
| Cytochrome P-450 CYP3A | 1 | 2016 | 114 | 0.140 |
Why?
|
| Dextrans | 1 | 2018 | 573 | 0.130 |
Why?
|
| Hair Cells, Auditory, Inner | 1 | 2018 | 199 | 0.130 |
Why?
|
| Cell Line, Tumor | 5 | 2020 | 16945 | 0.130 |
Why?
|
| Drug Administration Routes | 1 | 2015 | 150 | 0.120 |
Why?
|
| Feasibility Studies | 3 | 2024 | 5236 | 0.120 |
Why?
|
| Cell Line | 5 | 2021 | 15598 | 0.120 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2020 | 1089 | 0.120 |
Why?
|
| Hearing Disorders | 1 | 2014 | 126 | 0.120 |
Why?
|
| Nerve Regeneration | 2 | 2011 | 795 | 0.120 |
Why?
|
| Drug Implants | 1 | 2014 | 230 | 0.110 |
Why?
|
| Otoacoustic Emissions, Spontaneous | 3 | 2009 | 139 | 0.110 |
Why?
|
| Cell Communication | 1 | 2021 | 1652 | 0.110 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2014 | 274 | 0.110 |
Why?
|
| Abdominal Wound Closure Techniques | 1 | 2013 | 33 | 0.110 |
Why?
|
| Cyanoacrylates | 1 | 2013 | 46 | 0.110 |
Why?
|
| Malaria | 1 | 2023 | 1225 | 0.110 |
Why?
|
| Gels | 1 | 2014 | 419 | 0.110 |
Why?
|
| Respiratory Tract Infections | 1 | 2021 | 1010 | 0.110 |
Why?
|
| Menstrual Cycle | 1 | 2017 | 539 | 0.110 |
Why?
|
| User-Computer Interface | 1 | 1999 | 1397 | 0.110 |
Why?
|
| Robotics | 1 | 1999 | 819 | 0.100 |
Why?
|
| Hemodynamics | 1 | 2023 | 4167 | 0.100 |
Why?
|
| Decanoic Acids | 2 | 2009 | 68 | 0.100 |
Why?
|
| Ovary | 1 | 2017 | 958 | 0.100 |
Why?
|
| Dicarboxylic Acids | 2 | 2009 | 77 | 0.100 |
Why?
|
| Elastic Modulus | 1 | 2013 | 211 | 0.100 |
Why?
|
| Permeability | 2 | 2011 | 721 | 0.100 |
Why?
|
| Pharmaceutical Preparations | 2 | 2012 | 1087 | 0.100 |
Why?
|
| Nanofibers | 1 | 2012 | 66 | 0.100 |
Why?
|
| Plastics | 1 | 2012 | 115 | 0.100 |
Why?
|
| Microscopy, Fluorescence | 2 | 2016 | 2647 | 0.100 |
Why?
|
| Mice, Inbred BALB C | 1 | 2020 | 6206 | 0.100 |
Why?
|
| Electric Conductivity | 2 | 2009 | 405 | 0.090 |
Why?
|
| Scala Tympani | 1 | 2011 | 35 | 0.090 |
Why?
|
| Infusions, Parenteral | 1 | 2011 | 398 | 0.090 |
Why?
|
| Hepatic Stellate Cells | 1 | 2012 | 119 | 0.090 |
Why?
|
| Respiration, Artificial | 1 | 2022 | 2622 | 0.090 |
Why?
|
| Lipase | 1 | 2013 | 324 | 0.090 |
Why?
|
| Rats | 11 | 2013 | 23712 | 0.090 |
Why?
|
| Microinjections | 1 | 2011 | 321 | 0.090 |
Why?
|
| Lymphocytes | 1 | 2018 | 2610 | 0.090 |
Why?
|
| Retina | 1 | 2021 | 2652 | 0.090 |
Why?
|
| Peptide Hydrolases | 1 | 2013 | 621 | 0.090 |
Why?
|
| Blood-Air Barrier | 1 | 2009 | 24 | 0.090 |
Why?
|
| Embryonic Stem Cells | 2 | 2007 | 1262 | 0.090 |
Why?
|
| Dosage Forms | 1 | 2009 | 56 | 0.080 |
Why?
|
| Bioartificial Organs | 1 | 2009 | 47 | 0.080 |
Why?
|
| Administration, Cutaneous | 1 | 2011 | 712 | 0.080 |
Why?
|
| Cell Movement | 3 | 2012 | 5198 | 0.080 |
Why?
|
| Cell Aggregation | 2 | 2007 | 239 | 0.080 |
Why?
|
| Mastoid | 1 | 2009 | 100 | 0.080 |
Why?
|
| Infusion Pumps, Implantable | 1 | 2009 | 158 | 0.080 |
Why?
|
| Receptors, Glutamate | 1 | 2009 | 228 | 0.080 |
Why?
|
| Lizards | 1 | 2008 | 50 | 0.080 |
Why?
|
| Liver Neoplasms | 2 | 2014 | 4319 | 0.080 |
Why?
|
| Bacterial Physiological Phenomena | 1 | 2008 | 119 | 0.070 |
Why?
|
| Transducers | 1 | 2009 | 241 | 0.070 |
Why?
|
| Electronics | 1 | 2009 | 316 | 0.070 |
Why?
|
| Melanins | 1 | 2009 | 289 | 0.070 |
Why?
|
| Pulmonary Alveoli | 1 | 2009 | 650 | 0.070 |
Why?
|
| Tympanic Membrane | 1 | 2008 | 232 | 0.070 |
Why?
|
| Administration, Topical | 1 | 2008 | 703 | 0.070 |
Why?
|
| Glucocorticoids | 1 | 2015 | 2163 | 0.070 |
Why?
|
| Osteoporosis, Postmenopausal | 1 | 2009 | 396 | 0.070 |
Why?
|
| Carbon Dioxide | 1 | 2010 | 1146 | 0.060 |
Why?
|
| Neoplastic Stem Cells | 1 | 2013 | 1347 | 0.060 |
Why?
|
| Salicylates | 1 | 2005 | 127 | 0.060 |
Why?
|
| Nanoparticles | 2 | 2014 | 1953 | 0.060 |
Why?
|
| Mice | 5 | 2020 | 81402 | 0.060 |
Why?
|
| Regeneration | 1 | 2014 | 1508 | 0.060 |
Why?
|
| Rats, Inbred Lew | 4 | 2010 | 1155 | 0.060 |
Why?
|
| Uterine Hemorrhage | 1 | 2006 | 240 | 0.060 |
Why?
|
| Microcirculation | 2 | 2010 | 1269 | 0.060 |
Why?
|
| Patient Satisfaction | 2 | 2009 | 3457 | 0.060 |
Why?
|
| Archaeology | 1 | 2023 | 37 | 0.060 |
Why?
|
| Implants, Experimental | 3 | 2009 | 99 | 0.060 |
Why?
|
| Biology | 1 | 2006 | 289 | 0.060 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2024 | 1337 | 0.050 |
Why?
|
| Pandemics | 1 | 2023 | 8623 | 0.050 |
Why?
|
| Microscopy, Electron, Scanning | 3 | 2009 | 944 | 0.050 |
Why?
|
| Synaptic Transmission | 1 | 2009 | 1172 | 0.050 |
Why?
|
| Adenosine Monophosphate | 1 | 2024 | 230 | 0.050 |
Why?
|
| Cell Separation | 2 | 2005 | 1720 | 0.050 |
Why?
|
| Contraception | 1 | 2006 | 348 | 0.050 |
Why?
|
| Cell Survival | 5 | 2013 | 5790 | 0.050 |
Why?
|
| Cytoskeleton | 1 | 2007 | 1167 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 1 | 2020 | 22121 | 0.050 |
Why?
|
| Bone Density Conservation Agents | 1 | 2009 | 795 | 0.050 |
Why?
|
| Alanine | 1 | 2024 | 606 | 0.050 |
Why?
|
| Action Potentials | 1 | 2009 | 1830 | 0.050 |
Why?
|
| Polyethylene Glycols | 1 | 2007 | 1189 | 0.050 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2018 | 8967 | 0.050 |
Why?
|
| Embryo, Mammalian | 1 | 2007 | 1674 | 0.050 |
Why?
|
| Time Factors | 7 | 2014 | 39947 | 0.050 |
Why?
|
| Quality of Life | 1 | 2003 | 13338 | 0.050 |
Why?
|
| Biological Assay | 1 | 2023 | 626 | 0.040 |
Why?
|
| Porosity | 2 | 2013 | 350 | 0.040 |
Why?
|
| Actins | 1 | 2007 | 2049 | 0.040 |
Why?
|
| Light | 1 | 2005 | 1351 | 0.040 |
Why?
|
| Cell Membrane Permeability | 1 | 2021 | 575 | 0.040 |
Why?
|
| Inflammation | 2 | 2023 | 10746 | 0.040 |
Why?
|
| Transition Temperature | 2 | 2009 | 33 | 0.040 |
Why?
|
| Thrombosis | 1 | 2013 | 2940 | 0.040 |
Why?
|
| Myocardium | 2 | 2008 | 4700 | 0.040 |
Why?
|
| Image Enhancement | 1 | 2009 | 2882 | 0.040 |
Why?
|
| Biphenyl Compounds | 1 | 2003 | 1003 | 0.040 |
Why?
|
| Microscopy | 1 | 2023 | 886 | 0.040 |
Why?
|
| Male | 9 | 2018 | 360035 | 0.040 |
Why?
|
| Peripheral Blood Stem Cell Transplantation | 1 | 2019 | 263 | 0.040 |
Why?
|
| Diffusion | 2 | 2011 | 814 | 0.040 |
Why?
|
| Abortifacient Agents | 1 | 1997 | 11 | 0.040 |
Why?
|
| Blood Flow Velocity | 2 | 2013 | 1370 | 0.040 |
Why?
|
| Probability | 1 | 2003 | 2476 | 0.040 |
Why?
|
| Tetrazoles | 1 | 2003 | 907 | 0.040 |
Why?
|
| Biodegradation, Environmental | 2 | 2009 | 216 | 0.030 |
Why?
|
| Tubulin | 2 | 2013 | 692 | 0.030 |
Why?
|
| Molecular Weight | 2 | 2009 | 2188 | 0.030 |
Why?
|
| Fetal Membranes, Premature Rupture | 1 | 1997 | 137 | 0.030 |
Why?
|
| Cell Differentiation | 3 | 2009 | 11526 | 0.030 |
Why?
|
| Diabetic Nephropathies | 1 | 2003 | 973 | 0.030 |
Why?
|
| Computational Biology | 1 | 2008 | 3510 | 0.030 |
Why?
|
| Virus Replication | 1 | 2023 | 2435 | 0.030 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2005 | 2272 | 0.030 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2009 | 4063 | 0.030 |
Why?
|
| Health Care Costs | 2 | 2006 | 3240 | 0.030 |
Why?
|
| Cortisone | 1 | 2015 | 87 | 0.030 |
Why?
|
| Heart | 1 | 2008 | 4391 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2005 | 5865 | 0.030 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2000 | 954 | 0.030 |
Why?
|
| Female | 12 | 2020 | 391875 | 0.030 |
Why?
|
| Half-Life | 1 | 2015 | 652 | 0.030 |
Why?
|
| Dinoprostone | 1 | 1997 | 597 | 0.030 |
Why?
|
| Cytokines | 2 | 2023 | 7377 | 0.030 |
Why?
|
| Molecular Structure | 2 | 2008 | 1875 | 0.030 |
Why?
|
| Antihypertensive Agents | 1 | 2003 | 2018 | 0.030 |
Why?
|
| Uterus | 1 | 1997 | 649 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2009 | 8163 | 0.030 |
Why?
|
| Wettability | 1 | 2013 | 27 | 0.030 |
Why?
|
| Paxillin | 1 | 2013 | 86 | 0.030 |
Why?
|
| Oxytocin | 1 | 1997 | 402 | 0.030 |
Why?
|
| Electricity | 1 | 2014 | 181 | 0.030 |
Why?
|
| Kinetics | 2 | 2011 | 6377 | 0.030 |
Why?
|
| Stress Fibers | 1 | 2012 | 55 | 0.030 |
Why?
|
| Abortion, Induced | 1 | 1997 | 462 | 0.020 |
Why?
|
| Transforming Growth Factor beta2 | 1 | 2012 | 71 | 0.020 |
Why?
|
| Omentum | 2 | 2004 | 168 | 0.020 |
Why?
|
| Coloring Agents | 1 | 2014 | 559 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2010 | 7424 | 0.020 |
Why?
|
| Markov Chains | 2 | 2006 | 965 | 0.020 |
Why?
|
| Stem Cells | 1 | 2004 | 3522 | 0.020 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2013 | 383 | 0.020 |
Why?
|
| Biological Factors | 1 | 2012 | 157 | 0.020 |
Why?
|
| Endothelin-1 | 1 | 2012 | 302 | 0.020 |
Why?
|
| Elements | 1 | 2009 | 21 | 0.020 |
Why?
|
| Intensive Care Units | 1 | 2024 | 3742 | 0.020 |
Why?
|
| Laser-Doppler Flowmetry | 1 | 2010 | 239 | 0.020 |
Why?
|
| Pulmonary Surfactant-Associated Protein C | 1 | 2009 | 30 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2019 | 3392 | 0.020 |
Why?
|
| Hydrodynamics | 1 | 2011 | 167 | 0.020 |
Why?
|
| Proteolipids | 1 | 2009 | 113 | 0.020 |
Why?
|
| Breast Neoplasms | 2 | 2014 | 20985 | 0.020 |
Why?
|
| Polystyrenes | 1 | 2009 | 104 | 0.020 |
Why?
|
| Necrosis | 1 | 2013 | 1604 | 0.020 |
Why?
|
| Stomach | 1 | 2013 | 694 | 0.020 |
Why?
|
| Tablets | 1 | 2009 | 147 | 0.020 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 1 | 2009 | 161 | 0.020 |
Why?
|
| PC12 Cells | 1 | 2009 | 317 | 0.020 |
Why?
|
| Electron Probe Microanalysis | 1 | 2008 | 32 | 0.020 |
Why?
|
| Mechanical Phenomena | 1 | 2009 | 141 | 0.020 |
Why?
|
| Sugar Alcohols | 1 | 2008 | 18 | 0.020 |
Why?
|
| Semiconductors | 1 | 2009 | 100 | 0.020 |
Why?
|
| Lasers, Excimer | 1 | 2008 | 69 | 0.020 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2010 | 312 | 0.020 |
Why?
|
| Schwann Cells | 1 | 2009 | 197 | 0.020 |
Why?
|
| Alendronate | 1 | 2009 | 175 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2012 | 1844 | 0.020 |
Why?
|
| Injections, Subcutaneous | 1 | 2009 | 678 | 0.020 |
Why?
|
| RANK Ligand | 1 | 2009 | 318 | 0.020 |
Why?
|
| Cytochalasin D | 1 | 2007 | 91 | 0.020 |
Why?
|
| Hydrocortisone | 1 | 2015 | 1815 | 0.020 |
Why?
|
| Propanolamines | 1 | 2008 | 163 | 0.020 |
Why?
|
| Thiazolidines | 1 | 2007 | 69 | 0.020 |
Why?
|
| Nucleic Acid Synthesis Inhibitors | 1 | 2007 | 110 | 0.020 |
Why?
|
| Arteriovenous Shunt, Surgical | 1 | 2010 | 286 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2009 | 20078 | 0.020 |
Why?
|
| Tensile Strength | 1 | 2008 | 330 | 0.020 |
Why?
|
| Vibration | 1 | 2009 | 328 | 0.020 |
Why?
|
| Ventricular Function | 1 | 2008 | 406 | 0.020 |
Why?
|
| Cell Proliferation | 3 | 2009 | 10425 | 0.020 |
Why?
|
| Computer Simulation | 2 | 2011 | 6230 | 0.020 |
Why?
|
| MEDLINE | 1 | 2006 | 119 | 0.020 |
Why?
|
| Levonorgestrel | 1 | 2006 | 74 | 0.020 |
Why?
|
| Flow Injection Analysis | 1 | 2005 | 21 | 0.020 |
Why?
|
| Elasticity | 1 | 2008 | 653 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2009 | 20551 | 0.020 |
Why?
|
| Absorbable Implants | 1 | 2008 | 338 | 0.020 |
Why?
|
| Colon | 1 | 2013 | 1791 | 0.020 |
Why?
|
| Protein Precursors | 1 | 2009 | 1134 | 0.020 |
Why?
|
| Manufactured Materials | 1 | 2004 | 18 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2009 | 2468 | 0.020 |
Why?
|
| Acoustic Stimulation | 1 | 2009 | 1234 | 0.020 |
Why?
|
| Hair Cells, Auditory, Outer | 1 | 2005 | 99 | 0.020 |
Why?
|
| Anisotropy | 1 | 2008 | 1283 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2003 | 15820 | 0.020 |
Why?
|
| Cell Division | 2 | 2004 | 4461 | 0.010 |
Why?
|
| Umbilical Veins | 1 | 2005 | 426 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2007 | 23397 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2009 | 2060 | 0.010 |
Why?
|
| Femur | 1 | 2010 | 1308 | 0.010 |
Why?
|
| Organ Size | 1 | 2009 | 2252 | 0.010 |
Why?
|
| Contraceptives, Oral | 1 | 2006 | 554 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2009 | 2676 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2014 | 4903 | 0.010 |
Why?
|
| Pregnancy | 3 | 2017 | 29831 | 0.010 |
Why?
|
| Amlodipine | 1 | 2003 | 84 | 0.010 |
Why?
|
| Adult | 5 | 2023 | 220781 | 0.010 |
Why?
|
| Hypertension | 1 | 2003 | 8527 | 0.010 |
Why?
|
| Cross-Linking Reagents | 1 | 2006 | 686 | 0.010 |
Why?
|
| DNA Replication | 1 | 2009 | 1418 | 0.010 |
Why?
|
| Evoked Potentials, Auditory | 1 | 2005 | 530 | 0.010 |
Why?
|
| Blood Platelets | 1 | 2013 | 2478 | 0.010 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2009 | 1649 | 0.010 |
Why?
|
| Patient Preference | 1 | 2009 | 924 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 2 | 2006 | 5491 | 0.010 |
Why?
|
| Hearing Loss | 1 | 2009 | 781 | 0.010 |
Why?
|
| Transfection | 1 | 2009 | 5776 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2009 | 36362 | 0.010 |
Why?
|
| Liver Cirrhosis | 1 | 2012 | 1934 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2009 | 4010 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2009 | 4849 | 0.010 |
Why?
|
| Preoperative Care | 1 | 2009 | 2242 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2006 | 64591 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2003 | 41366 | 0.010 |
Why?
|
| Glass | 1 | 2000 | 115 | 0.010 |
Why?
|
| Psychometrics | 1 | 2009 | 3063 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2003 | 12127 | 0.010 |
Why?
|
| Algorithms | 1 | 1999 | 14002 | 0.010 |
Why?
|
| Middle Aged | 4 | 2009 | 220382 | 0.010 |
Why?
|
| Biomedical Engineering | 1 | 2000 | 289 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2008 | 4106 | 0.010 |
Why?
|
| Peptides | 1 | 2009 | 4338 | 0.010 |
Why?
|
| Life Expectancy | 1 | 2003 | 1240 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2012 | 9410 | 0.010 |
Why?
|
| Contrast Media | 1 | 2009 | 5310 | 0.010 |
Why?
|
| Proteins | 1 | 2010 | 6033 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2009 | 12320 | 0.010 |
Why?
|
| Base Sequence | 1 | 2006 | 12449 | 0.010 |
Why?
|
| Pregnancy Trimester, Second | 1 | 1997 | 731 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2009 | 14661 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2005 | 10759 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2009 | 9176 | 0.010 |
Why?
|
| DNA | 1 | 2006 | 7208 | 0.010 |
Why?
|
| Treatment Failure | 1 | 1997 | 2642 | 0.010 |
Why?
|
| Aged | 3 | 2009 | 168840 | 0.010 |
Why?
|
| Gestational Age | 1 | 1997 | 3574 | 0.000 |
Why?
|
| Liver Transplantation | 1 | 2000 | 2332 | 0.000 |
Why?
|
| Phenotype | 1 | 2005 | 16585 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 2009 | 58859 | 0.000 |
Why?
|
| Young Adult | 1 | 2009 | 59068 | 0.000 |
Why?
|
| Adolescent | 1 | 2009 | 88196 | 0.000 |
Why?
|